Exendin-9,39

• Recruiting NCT NCT00992901

  Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

  Not yet reported The University of Texas Health Science Center at San Antonio 160 participants Est. completion 2027-08 2 sites
  Other conditions: Post Bariatricsurgery, Hypoglycemia
  View official trial listing →
• Recruiting NCT NCT01803451

  Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  Not yet reported The University of Texas Health Science Center at San Antonio 80 participants Est. completion 2027-08 2 sites
  Other conditions: Post-bariatric Surgery
  View official trial listing →
• Recruiting NCT NCT02823665

  The Effects of Bariatric Surgeries on Glucose Metabolism

  Not yet reported The University of Texas Health Science Center at San Antonio 200 participants Est. completion 2027-08 2 sites
  Other conditions: Post Bariatric Surgery, Gastric Bypass, Sleeve Gastrectomy, Hypoglycemia After Gastric Bypass
  View official trial listing →
• Recruiting NCT NCT06967558

  The Role of Islet GLP-1 in the Pathogenesis of Prediabetes

  Not yet reported Mayo Clinic 60 participants Est. completion 2028-03-31 1 site
  Prediabetes
  View official trial listing →
• Recruiting NCT NCT07019519

  POTS-FLOW: Interplay Between Gut Hormones and Autonomic Postprandial Blood Flow Regulation in Patients With POTS

  Not yet reported University of Copenhagen 30 participants Est. completion 2026-09-30 1 site
  Other conditions: Postural Orthostatic Tachycardia Syndrome (POTS), Healthy
  View official trial listing →
• Recruiting NCT NCT07806695

  Islet Function in Gestational Diabetes

  Not yet reported Mayo Clinic 90 participants Est. completion 2030-12 1 site
  Other conditions: Gestational Diabetes Mellitus
  View official trial listing →
• Completed NCT NCT00393445

  Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans

  Not yet reported Ludwig-Maximilians - University of Munich 6 participants Est. completion 2007-05 1 site
  Other conditions: Hyperglycemia
  View official trial listing →
• Completed NCT NCT00468091

  Effects of Exendin(9-39) on Gastroduodenal Motility

  Not yet reported Ludwig-Maximilians - University of Munich 10 participants Est. completion 2000-09 1 site
  Other conditions: Digestive Physiology, Gastrointestinal Motility, Gastrointestinal Hormones, Glucagon-like Peptide 1, Exendin (9-39)
  View official trial listing →
• Completed NCT NCT00551590

  Effect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes Mellitus

  Not yet reported Ludwig-Maximilians - University of Munich 24 participants Est. completion 2011-09 1 site
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT00571324

  Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism

  Not yet reported, Not yet reported Diva De Leon 9 participants Est. completion 2014-12 1 site
  Other conditions: Congenital Hyperinsulinism
  View official trial listing →
• Terminated NCT NCT00835328

  Effect of Exendin (9-39) on Glucose Requirements to Maintain Euglycemia

  Not yet reported, Not yet reported Diva De Leon 14 participants Est. completion 2017-01-28 1 site
  Other conditions: Congenital Hyperinsulinism
  View official trial listing →
• Completed NCT NCT00897676

  Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity

  Not yet reported, Not yet reported Diva De Leon 17 participants Est. completion 2017-01 1 site
  Other conditions: Congenital Hyperinsulinism
  View official trial listing →
• Completed NCT NCT00980083

  GLP-1 - Regulatory Mechanism of Postprandial Glycemia

  Not yet reported Ludwig-Maximilians - University of Munich 12 participants Est. completion 2007-12 1 site
  Other conditions: Healthy Subjects, Gastric Emptying
  View official trial listing →
• Withdrawn NCT NCT01152333

  The Role of GLP-1 in Satiety Perception in Humans

  Not yet reported University of Washington Est. completion 2016-07 1 site
  Other conditions: Appetite Regulation, Obesity
  View official trial listing →
• Completed NCT NCT01162499

  Role of Glucagon-Like Peptide-1 in Postprandial Hypoglycemia

  Not yet reported Diva De Leon 7 participants Est. completion 2014-12 1 site
  Other conditions: Postprandial Hypoglycemia
  View official trial listing →
• Completed NCT NCT01181986

  The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes

  Not yet reported Carl T. Hayden VA Medical Center 76 participants Est. completion 2012-12 1 site
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT01281228

  The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes

  Not yet reported Amsterdam UMC, location VUmc 48 participants Est. completion 2013-10 1 site
  Type 2 diabetes Other conditions: Diabetes Mellitus, Obesity
  View official trial listing →
• Completed NCT NCT01363609

  Effects of Glucagon Like Peptide-1(GLP-1) and Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in Diabetes

  Not yet reported Amsterdam UMC, location VUmc 50 participants Est. completion 2015-01 1 site
  Type 2 diabetes Other conditions: Obesity
  View official trial listing →
• Completed NCT NCT01449019

  The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)

  Not yet reported Ludwig-Maximilians - University of Munich 24 participants Est. completion 2010-07 2 sites
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT01579981

  The Importance of GLP-1 in Post RYGB Improvement in Glycaemic Control Type 2 Diabetic Subjects

  Not yet reported Hvidovre University Hospital 9 participants Est. completion 2012-11 1 site
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT01701973

  Effect of DPP4 Inhibition on Growth Hormone Secretion

  Not yet reported Vanderbilt University 44 participants Est. completion 2017-05 1 site
  Other conditions: Obesity
  View official trial listing →
• Status unknown NCT NCT01729299

  Ghrelin Effect on Beta Cell Function in Health and Disease

  Not yet reported David Dalessio 30 participants Est. completion 2014-04 2 sites
  Other conditions: Diabetes
  View official trial listing →
• Status unknown NCT NCT01760772

  Effect of GLP-1 on Postprandial Lipid Metabolism

  Not yet reported David Dalessio 42 participants Est. completion 2015-02 1 site
  Other conditions: Heart Disease
  View official trial listing →
• Completed NCT NCT01795144

  Incretin Regulation of Insulin Secretion in Monogenic Diabetes

  Not yet reported University of Chicago 10 participants Est. completion 2017-03 1 site
  Other conditions: Monogenic Diabetes
  View official trial listing →
• Completed NCT NCT01843855

  The Contribution of Incretin Hormones to the Amelioration of Glucose Metabolism After Roux-en-Y Gastric Bypass

  Not yet reported Adrian Vella 12 participants Est. completion 2013-09 1 site
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT01843881

  The Contribution of Incretin Hormones to Post-prandial Glucose Metabolism After Roux-en-Y Gastric Bypass

  Not yet reported Adrian Vella 20 participants Est. completion 2013-12 1 site
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT01865760

  Etiology, Assessment and Treatment of Post-gastric Bypass Severe Hypoglycemia

  Not yet reported University of Aarhus 33 participants Est. completion 2016-03 1 site
  Other conditions: Obesity, Hypoglycemia, Surgery
  View official trial listing →
• Completed NCT NCT01900340

  Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in Humans

  Not yet reported University Hospital, Basel, Switzerland 12 participants Est. completion 2012-12 1 site
  Other conditions: Appetite and General Nutritional Disorders
  View official trial listing →
• Completed NCT NCT01918566

  The Role of Endogenous GLP-1 (Glycolipoprotein) in Regulating Glucose Stimulated Brain Activity

  Not yet reported University Hospital, Basel, Switzerland 12 participants Est. completion 2013-03 1 site
  Other conditions: Exploratory Behavior
  View official trial listing →
• Completed NCT NCT02050074

  The Role of Metformin and Colesevelam in Human GLP-1 Secretion

  Not yet reported University Hospital, Gentofte, Copenhagen 12 participants Est. completion 2014-09 1 site
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT02128581

  A Dose-response of the Effects of Exendin-9,39 on GI Symptoms and Food Intake

  Not yet reported Mayo Clinic 3 participants Est. completion 2019-07 1 site
  Other conditions: Obesity, Diabetes, Roux-en-Y Gastric Bypass
  View official trial listing →
• Completed NCT NCT02170870

  Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus

  Not yet reported Mayo Clinic 104 participants Est. completion 2017-11-17 1 site
  Other conditions: Dyspepsia, Diabetes Mellitus With Gastrointestinal Symptoms
  View official trial listing →
• Completed NCT NCT02287285

  Determinants of Diabetes Remission After Gastric Bypass Surgery

  Not yet reported Blandine Laferrere 25 participants Est. completion 2019-07 1 site
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT02336659

  Influence of Gut Hormones on Food Intake After Roux-en-Y Gastric Bypass Surgery

  Not yet reported Hvidovre University Hospital 12 participants Est. completion 2016-06 1 site
  Other conditions: Severe Obesity
  View official trial listing →
• Terminated NCT NCT02550145

  Role of GLP-1 in Hyperinsulinemic Hypoglycemia Post-bariatric Surgery

  Not yet reported Tracey McLaughlin 10 participants 1 site
  Other conditions: Hypoglycemia
  View official trial listing →
• Completed NCT NCT02639130

  GLP-1 Mediating DPP-4 Inhibition in Type 2 Diabetes

  Not yet reported Diabeteszentrum Bad Lauterberg im Harz 67 participants Est. completion 2010-01 1 site
  Type 2 diabetes
  View official trial listing →
• Withdrawn NCT NCT02697253

  Mechanisms Underlying Predictors of Success From Obesity Surgery

  Not yet reported Icahn School of Medicine at Mount Sinai Est. completion 2021-07-29 1 site
  Other conditions: Obesity
  View official trial listing →
• Completed NCT NCT02746757

  Glucagon Like Peptide-1 in Remote Ischemic Conditioning

  Not yet reported Karolinska Institutet 12 participants Est. completion 2018-01 1 site
  Other conditions: Healthy Volunteers
  View official trial listing →
• Completed NCT NCT02771574

  Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric Hypoglycemia

  Not yet reported Tracey McLaughlin 19 participants Est. completion 2017-06 1 site
  Other conditions: Post Bariatric Hypoglycemia
  View official trial listing →
• Completed NCT NCT02779075

  Exendin-9,39 and Satiety After Bariatric Surgery

  Not yet reported Mayo Clinic 29 participants Est. completion 2019-12 1 site
  Other conditions: Obesity
  View official trial listing →
• Terminated NCT NCT02844907

  Regulation of Insulin Secretion by the GLP-1 Receptor

  Not yet reported VA Office of Research and Development 6 participants Est. completion 2021-12-31 1 site
  Other conditions: Insulin Secretion
  View official trial listing →
• Completed NCT NCT02971631

  Gastrectomy, Eating Behaviour and GLP-1

  Not yet reported Cambridge University Hospitals NHS Foundation Trust 5 participants Est. completion 2018-09-16 1 site
  Other conditions: Gastric Cancer, Dumping Syndrome
  View official trial listing →
• Completed NCT NCT02996812

  Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia

  Not yet reported Tracey McLaughlin 9 participants Est. completion 2016-08 1 site
  Other conditions: Hyperinsulinemia Hypoglycemia
  View official trial listing →
• Completed NCT NCT03013296

  Delinieation of GIP's Effects During a Meal in Humans Using GIP Receptor Antagonisation (GA-4)

  Not yet reported University Hospital, Gentofte, Copenhagen 12 participants Est. completion 2018-09 1 site
  Other conditions: Glucose Metabolism Disorders
  View official trial listing →
• Completed NCT NCT03101930

  Cardiovascular Effects of GLP-1 Receptor Activation

  Not yet reported Vanderbilt University Medical Center 329 participants Est. completion 2021-06-24 1 site
  Prediabetes Other conditions: Obesity
  View official trial listing →
• Completed NCT NCT03133741

  Inhibition of the Endogenous GIP Response With a GIP Receptor Antagonist

  Not yet reported University Hospital, Gentofte, Copenhagen 18 participants Est. completion 2017-07-01 1 site
  Other conditions: Glucose Metabolism Disorders
  View official trial listing →
• Completed NCT NCT03241303

  Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small Intestines

  Not yet reported University Hospital, Gentofte, Copenhagen 15 participants Est. completion 2018-01-01 1 site
  Other conditions: Glucose Metabolism Disorders
  View official trial listing →
• Completed NCT NCT03246451

  The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin in Patients With T2D

  Not yet reported University Hospital, Gentofte, Copenhagen 15 participants Est. completion 2017-12-10 1 site
  Other conditions: Glucose Metabolism Disorders
  View official trial listing →
• Completed NCT NCT03373435

  Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia

  Not yet reported Eiger BioPharmaceuticals 18 participants Est. completion 2019-03-15 5 sites
  Other conditions: Postbariatric Hypoglycemia
  View official trial listing →
• Completed NCT NCT03950245

  Incretin Hormone Antagonism After Bariatric Surgery

  Not yet reported Hvidovre University Hospital 36 participants Est. completion 2021-04-16 2 sites
  Other conditions: Bariatric Surgery
  View official trial listing →
• Completed NCT NCT04347252

  Glucagon Regulation of Glucose Metabolism

  Not yet reported David D'Alessio, M.D. 19 participants Est. completion 2021-04-16 1 site
  Other conditions: Insulin Secretion
  View official trial listing →
• Completed NCT NCT04652479

  Avexitide Safety and Efficacy to Treat Acquired Hyperinsulinemic Hypoglycemia

  Not yet reported Dr. Tracey McLaughlin, MD 25 participants Est. completion 2022-06-30 1 site
  Other conditions: Acquired Hyperinsulinemic Hypoglycemia
  View official trial listing →
• Completed NCT NCT05177653

  Separate and Combined Extrapancreatic Effects of the Incretin Hormones

  Not yet reported University Hospital, Gentofte, Copenhagen 13 participants Est. completion 2023-03-03 1 site
  Other conditions: Pancreatectomy; Hyperglycemia
  View official trial listing →
• Status unknown NCT NCT06498063

  The Underlying Mechanisms Regarding the Effect of Glucagon on the Kidneys Will be Investigated in Healthy Males.

  Not yet reported Ali Asmar 10 participants Est. completion 2025-07-31 1 site
  Other conditions: Kidney Diseases
  View official trial listing →
• Active, not recruiting NCT NCT06747468

  Avexitide for Treatment of Post-Bariatric Hypoglycemia

  Not yet reported Amylyx Pharmaceuticals Inc. 75 participants Est. completion 2027-02 21 sites
  Other conditions: Post Bariatric Hypoglycemia
  View official trial listing →
• Not yet recruiting NCT NCT06872060

  The Effects of Glucagon on Renal Regional Blood Flow in Humans Measured by Magnetic Resonance.

  Not yet reported Bispebjerg Hospital 10 participants Est. completion 2027-11-01
  Other conditions: Kidney Diseases
  View official trial listing →
• Not yet recruiting NCT NCT06972407

  The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans

  Not yet reported Mayo Clinic 80 participants Est. completion 2029-03-01 1 site
  Other conditions: Genetic Predisposition, Type2diabetes
  View official trial listing →
• Completed NCT NCT07373236

  The Effect of Endogenous GLP-1 on Glucagon Secretion in Type 1 Diabetes

  Not yet reported Asger Lund, MD 12 participants Est. completion 2026-04-09 1 site
  Other conditions: Type 1 Diabetes
  View official trial listing →
• Available NCT NCT07582874

  An Expanded Access Protocol to Provide Avexitide in Patients With Post-Bariatric Hypoglycemia

  Amylyx Pharmaceuticals Inc. 4 sites
  Other conditions: Post-bariatric Hypoglycemia
  View official trial listing →

Not yet reported.

Not yet reported.

• ClinicalTrials.gov — NCT02779075

No related coverage yet.